Lv61
2138 积分 2024-11-04 加入
Impact of loss-of-function variations of PCSK9 on LDLR interaction and dynamics: Implications for heart function
6小时前
已完结
Understanding the activation mechanism of GLP-1R/GIPR by dual agonist Tirzepatide via molecular dynamics and protein-peptide binding
2天前
已完结
Allosteric inhibition of the PCSK9–LDLR interaction: structural insights for small molecule design
17天前
已完结
Mapping the distribution and affinities of ligand interaction sites on human serum albumin
2个月前
已完结
Ligand Design with Accelerated Disulfide Formation with Serum Albumin to Extend Blood Retention
2个月前
已完结
Derivatization with fatty acids in peptide and protein drug discovery
3个月前
已完结
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation
3个月前
已完结
Conserved class B GPCR activation by a biased intracellular agonist
3个月前
已完结
Ecnoglutide, a biased GLP-1 receptor agonist as a potential new player for type 2 diabetes management?
4个月前
已完结
The therapeutic age of the neonatal Fc receptor
4个月前
已完结
皖公网安备34019202002308
